Heterophilic Antibodies Resulting in False Positive Elevation of PSA After Radical Prostatectomy

Heterophilic Antibodies Resulting in False Positive Elevation of PSA After Radical Prostatectomy

Bibliographic Details
Main Authors:	Wafa Asha, MD, Elizabeth Obi, MD, Rahul Tendulkar, MD
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	Advances in Radiation Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2452109423001173

Similar Items

Circulating Heterophile Antibodies Causing Cardiac Troponin Elevation
by: Luís Graça Santos, MD, et al.
Published: (2020-03-01)

Persistently Elevated Troponin Level Caused by Heterophile Antibodies
by: Ivana Sopek Merkaš, MD, et al.
Published: (2020-08-01)

False-positive cardiac troponin T due to assay interference with heterophilic antibodies
by: N Shayanfar, et al.
Published: (2008-08-01)

False Positive Findings of [18F]PSMA-1007 PET/CT in Patients After Radical Prostatectomy with Undetectable Serum PSA Levels
by: Marina Orevi, et al.
Published: (2022-06-01)

Falsely positive HIV test due to Interference by heterophile antibodies in a patient with Mantle cell lymphoma treated with Rituximab
by: Mariano Fiorenza, et al.
Published: (2022-09-01)

Heterophile antibody positive, acute cytomegaloviral infection in an immunocompetent pre-teen: An atypical presentation of an atypical infection
by: Junaid Raja, MD, MSPH, MS, et al.
Published: (2015-01-01)

The impact of persistently elevated PSA levels on progression and survival of patients undergoing cytoreductive radical prostatectomy for oligometastatic prostate cancer
by: D. Cannoletta, et al.
Published: (2020-10-01)

Survival of patients with prostate cancer and normal PSA levels treated by radical prostatectomy
by: Marcos F. Dall'oglio, et al.
Published: (2005-06-01)

Eletriptan (Relpaxa™) Causing False Positive Elevations In Urinary Metanephrines
by: Zachary W. Bloomer, MD, et al.
Published: (2020-11-01)

Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data
by: Blanca Lumbreras, et al.
Published: (2022-12-01)

Gleason score as predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomy
by: Marbele S. Guimaraes, et al.
Published: (2008-02-01)

Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience
by: Desgrandchamps François, et al.
Published: (2008-01-01)

The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy
by: Antonio B. Porcaro, et al.
Published: (2016-03-01)

Patient Decision Making Prior to Radical Prostatectomy
by: Çağatay Doğan MD, et al.
Published: (2017-01-01)

The specificity of naturally occurring heterophile antibodies in normal rabbit serum.
by: Kennett, R, et al.
Published: (1976)

Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: The ProtecT three-arm RCT
by: Hamdy, FC, et al.
Published: (2020)

Oncological outcomes in robot-assisted radical prostatectomy: the value of PSA density as a preoperative predictive factor
by: Roser Vives Dilme, et al.
Published: (2024-02-01)

Is PSA Still the Best Predictor for Biochemical Recurrence after Radical Prostatectomy in High-Risk Prostate Cancer?
by: Serkan Akan, et al.
Published: (2022-10-01)

Seminal vesicle sparing robotic radical prostatectomy – no different interpretation of postoperative PSA follow-up required?
by: Patrick Betschart, et al.
Published: (2019-01-01)

Long-term rates of undetectable PSA with initial observation and delayed salvage radiotherapy after radical prostatectomy
by: Andreas Bohle
Published: (2010-02-01)

Experiences of Uncertainty in Men With an Elevated PSA
by: Caitlin Biddle MA, et al.
Published: (2017-01-01)

Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
by: Steuber, T, et al.
Published: (2006)

Prospective evaluation of radical prostatectomy without prior biopsy based on PSA or DRE, mpMRI and PSMA-PET
by: C. Stief, et al.
Published: (2023-11-01)

The effect of heterophilic antibody interference in thyroglobulin measurement on different immunoassay devices
by: Kutluay Ismet Gamze, et al.
Published: (2023-03-01)

Prognostic significance of a novel indicator (PSApostd3/PSApre) for PSA recurrence in patients after radical prostatectomy
by: Zhou Z, et al.
Published: (2019-06-01)

Reversible adrenal insufficiency and heterophile antibodies in a case of autoimmune polyendocrinopathy syndrome
by: Sandeep Kharb, et al.
Published: (2013-01-01)

Heterophile Antibody Interference led to Unneeded Chemotherapy in a Testicular Cancer Patient
by: Daniele G. Soares, et al.
Published: (2016-11-01)

Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.
by: O'Brien, M, et al.
Published: (2009)

Comparison of Satisfaction With Penile Prosthesis Implantation in Patients With Radical Prostatectomy or Radical Cystoprostatectomy to the General Population
by: Skyler Howell, BS, et al.
Published: (2021-02-01)

Role of PSA Density and MRI in PSA Interpretation. Comment on Lumbreras et al. Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data. <i>Cancers</i> 2023, <i>15</i>, 261
by: Joshua S. Jue, et al.
Published: (2023-05-01)

<sup>68</sup>Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy
by: Finn Edler von Eyben, et al.
Published: (2021-03-01)

Pre-radiotherapy PSA Level as a Predictor for Biochemical Control in Prostate Cancer Patients Receiving Radiotherapy after Radical Prostatectomy
by: Din-Li Tsan, et al.
Published: (2013-04-01)

Reduction in PSA messenger-RNA expression and clinical recurrence in patients with prostatic cancer undergoing neoadjuvant therapy before radical prostatectomy
by: Baruffi Marco, et al.
Published: (2004-04-01)

Results of the nerve-sparing radical prostatectomy in obese patients
by: E. A. Sokolov, et al.
Published: (2020-07-01)

FUNCTIONAL RESULTS OF ENDOSCOPIC EXTRAPERITONEAL RADICAL INTRAFASCIAL PROSTATECTOMY
by: D. V. Perlin, et al.
Published: (2018-03-01)

The Results of Adjuvant and Salvage Radiotherapy Following Radical Prostatectomy
by: Selvi Dinçer, et al.
Published: (2021-06-01)

On the Effect of Heterophilic Antibodies on Serum Levels of Cardiac Troponins: A Brief Descriptive Review
by: Aleksey Michailovich Chaulin
Published: (2022-07-01)

Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical Prostatectomy
by: Shivam M. Kharod, MD, et al.
Published: (2021-03-01)

Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens
by: Nelson Gianni de Lima, et al.
Published: (2013-06-01)

Changes of Radiation Treatment Concept Based on 68Ga-PSMA-11-PET/CT in Early PSA-Recurrences After Radical Prostatectomy
by: Dirk Bottke, et al.
Published: (2021-06-01)